Next 10 |
DarioHealth (NASDAQ: DRIO) , a leader in the global digital health market, is planning to release its financial results for the first quarter 2024, the period ended March 31, 2024. According to the announcement, the company will release the report on May 15, 2024, before the market opens. In addi...
DarioHealth to Report First Quarter 2024 Results on Wednesday, May 15th PR Newswire Company to host conference call and webcast at 8:30am ET NEW YORK , May 7, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the globa...
Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes PR Newswire Quasi-randomized study demonstrates the value of Dario's integrated approach to provide one solu...
2024-04-22 17:28:00 ET More on DarioHealth DarioHealth Corp. (DRIO) Q4 2023 Earnings Call Transcript DarioHealth reports Q4 results Dario buys Twill to create digital health platform across most prevalent chronic conditions Seeking Alpha’s Quant Rating...
DarioHealth (NASDAQ: DRIO) , a leader in the global digital health market, has announced that two employers, a national supply chain company and a regional education organization, have selected its integrated chronic condition management solutions. According to the announcement, beginning in the ...
Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution PR Newswire Dario selected to provide integrated and proven solutions to improve employee cardiometabolic health NEW YORK , April 18, 2024 /PRNewswire/ -- DarioHealth Corp....
DarioHealth (NASDAQ: DRIO) , a leader in the global digital health market, has published two studies in the leading peer-reviewed journal for digital health and medicine, the “Journal of Internet Medicine. ” The studies include a randomized controlled trial (“RCT”) de...
Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health PR Newswire Studies include a Randomized Controlled Trial demonstrating significant reduction in perceived stress for teens NEW YORK , April 10, 2024 /PRNewswi...
DarioHealth (NASDAQ: DRIO) , a leader in the global digital therapeutics (“DTx”) market, has announced that it will release its financial results for the fourth quarter ended Dec. 31, 2023, before market opens on Thursday, March 28, 2024. At 8:30 a.m. Eastern Time on that same day, ...
Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health PR Newswire Dario selected to provide integrated approach to improve employee cardiometabolic health - including support for those taking a GLP-1 medication - musculoskeletal...
News, Short Squeeze, Breakout and More Instantly...
DarioHealth (NASDAQ: DRIO) , a leader in the global digital health market, is planning to release its financial results for the first quarter 2024, the period ended March 31, 2024. According to the announcement, the company will release the report on May 15, 2024, before the market opens. In addi...
DarioHealth to Report First Quarter 2024 Results on Wednesday, May 15th PR Newswire Company to host conference call and webcast at 8:30am ET NEW YORK , May 7, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the globa...
Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes PR Newswire Quasi-randomized study demonstrates the value of Dario's integrated approach to provide one solu...